Intraoperative Anesthesiology Management and Patient Outcomes for Surgical Revascularization for Moyamoya Disease: A

George W Williams1, William S Jones2, Rabail Chaudhry3

  • 1Department of Anesthesiology, University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States.

Abstract

Insights

Anesthetic management for Moyamoya disease (MMD) using remifentanil showed improved hemodynamic stability and reduced hospital length of stay (LOS) compared to fentanyl. This shift in anesthetic agents may enhance patient outcomes in MMD surgical revascularization.

Area of Science:

  • Anesthesiology
  • Neurosurgery
  • Cerebrovascular Medicine

Background:

  • Moyamoya disease (MMD) is a rare cerebrovascular condition impacting adults, often presenting with headaches or stroke.
  • Anesthetic management for MMD poses challenges, potentially influencing neurologic outcomes and hospital length of stay (LOS).

Purpose of the Study:

  • To assess anesthetic agent usage in Moyamoya disease (MMD) patients undergoing surgical revascularization.
  • To evaluate the impact of anesthetic choices on hemodynamic stability and hospital LOS in MMD patients.

Main Methods:

  • Literature search for MMD etiology, epidemiology, and intraoperative anesthetic management.
  • Retrospective review of MMD cases (2009-2015) involving craniotomy and surgical revascularization.
  • Comparison of anesthetic agents, LOS, and adverse events between two case cohorts.

Main Results:

  • Increased use of remifentanil and desflurane, with decreased fentanyl use, observed between the two study periods.
  • A reduction in mean hospital LOS from 3.9 to 3.3 days was noted between the cohorts.
  • Remifentanil use correlated with more stable hemodynamics compared to fentanyl.

Conclusions:

  • The increased adoption of remifentanil in MMD anesthesia is likely due to its superior hemodynamic stability during anesthetic procedures.
  • Remifentanil administration was associated with lower systolic and diastolic pressures and heart rates than fentanyl.
  • Anesthetic management strategies may play a crucial role in optimizing outcomes for MMD patients.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
493
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
920
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
886
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
715
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.0K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
548